The stock market is forward looking, almost everyone knows that. So with a share price down over 80% from recent highs, and an ask of $4 with virtually no buying interest, what's the message here? It certainly is not saying imun going to $160 lol. And why is cbli showing weakness after merger approval?
More important, what's the message from imun ceo to shareholders who have lost so much? Why is the value of imun's cyto holdings being totally ignored?
The new merged cyto and imun have one thing in common - the likelihood of significant dilution.
News 
Market Data 
Discover 
